FINHUB Insights

LH · Q3 FY25 · Jul 1 – Sep 30, 2025

Labcorp Q3 FY25: where the revenue came from and where it went

Labcorp Q3 FY25: revenue $3.6B (+9% year over year). Net profit $0.26B. Largest cohort Diagnostics $2.8B. The whole income statement as a sankey diagram from the SEC filing.

Period
Jul 1 – Sep 30, 2025
Reported
Oct 31, 2025 10-Q
Sankey diagram of Labcorp's income statement for Q3 FY25: revenue of $3.56 billion splits into segments and flows out into costs, taxes and net profit.

Tap the diagram to enlarge · figures in billions of dollars

Revenue$3.56B +9% year over year
Gross profit$1.03B 29% margin
Operating profit$0.40B 11% margin
Net profit$0.26B 7% margin

The numbers

All figures in billions of U.S. dollars, for Q3 FY25 (period ends Sep 30, 2025).
ItemValueShare of revenueYear over year
Revenue 3.56 100% +9%
Diagnostics 2.77 78% +8%
Biopharma laboratory 0.80 22% +8%
Cost of revenue−2.5471%
Gross profit1.0329% margin+1pp
SG&A−0.5516%−2pp
Other−0.082%+0pp
Operating profit0.4011% margin+3pp
Tax−0.08
Interest & other costs−0.06
Net profit0.267%+2pp
Filing on EDGAR More quarters of LH

Source of the numbers: structured XBRL data from the filing (10-Q). The diagram is generated automatically and checked against EDGAR before release. How we calculate it → About and methodology.